Yashna Singh

Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Antiretroviral Therapy Adherence Interventions in the Era of Universal Test and Treat: A Hybrid Systematic-Narrative Literature Review of Global Evidence.

Antiretroviral Therapy Adherence Interventions in the Era of Universal Test and Treat: A Hybrid Systematic-Narrative Literature Review of Global Evidence.

Journal: AIDS and behavior

Published: August 10, 2025

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Journal: Nature communications

Published: April 09, 2025

The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans.

The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans.

Journal: Southern African journal of HIV medicine

Published: February 05, 2025

Oral antiretroviral adherence interventions in the era of U=U.

Oral antiretroviral adherence interventions in the era of U=U.

Journal: The lancet. HIV

Published: November 08, 2024

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Journal: The New England journal of medicine

Published: July 24, 2024

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.

Journal: EClinicalMedicine

Published: July 19, 2024

HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.

HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.

Journal: Journal of the International AIDS Society

Published: June 16, 2023

Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.

Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.

Journal: AIDS research and therapy

Published: June 02, 2023

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.

Journal: The lancet. HIV

Published: April 21, 2023

A Review on Microbial Species for Forensic Body Fluid Identification in Healthy and Diseased Humans.

A Review on Microbial Species for Forensic Body Fluid Identification in Healthy and Diseased Humans.

Journal: Current microbiology

Published: April 11, 2023

Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.

Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 01, 2020

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).

Journal: PLoS medicine

Published: February 13, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026